We demonstrate that bladder tumors not enriched for APOBEC mutagenesis frequently harbor mutations in FGFR3 or the RAS family of oncogenes, and we also demonstrate that APOBEC3A is expressed at significantly higher levels in the basal subtype of bladder cancer, compared to other subtypes. The gene discussed is FGFR3; the disease is urinary bladder cancer.